China-based 3D printing pharma startup secures funding worth $50 M

Retrieved on: 2021-06-24 11:37:30

Tags for this article:

Click the tags to see associated articles and topics

China-based 3D printing pharma startup secures funding worth $50 M. View article details on hiswai:

Excerpt

This round of investment was co-led by Matrix Partners China and CPE, with participation from Shanghai Sci-Tech Innovation Center Capital (SSICC) ...

Article found on: www.biospectrumasia.com